Navigation Links
Opto-Acoustic Transducers Remove Blockages. ICAP Patent Brokerage Announces for Auction Important Patents for Medical Techniques and Devices That Perform Blockage Removal Using Lasers, Ultrasonics, and Fiber Optics
Date:3/19/2012

LOS ANGELES, March 19, 2012 /PRNewswire/ -- ICAP Patent Brokerage, a division of ICAP plc and the world's largest intellectual property brokerage firm and organizer of ICAP Ocean Tomo Auctions, is offering for auction licenses to important patents for medical techniques and devices that perform blockage removal using lasers, ultrasonics, and fiber optics from Lawrence Livermore National Laboratory. The lot will be included in the 15th ICAP Ocean Tomo IP Auction on March 29, 2012, at Terranea Resort near Los Angeles, California. 

(Logo:  http://photos.prnewswire.com/prnh/20100614/CG20517LOGO)

Background

In ultrasound angioplasty, an ultrasonic transducer is connected to a catheter for transmitting vibrations to a working tip at its distal end in close proximity to the occlusion. However, there is loss of energy through bends and curves along with heating of the tissue. In laser angioplasty, laser light is directed down an optical fiber to impinge directly on the occluding material to remove it. However, laser angioplasty devices may cause damage or destruction of the surrounding tissues. Improved medical devices are required for thrombolysis and angioplasty.

Key Characteristics & Benefits

This patent portfolio discloses improved devices for removing blockages or clots in vessels.

  • The devices include an opto-acoustic transducer located at the end of a fiber optic within a catheter for removal of vascular blockage or other luminal occlusions.
  • The optical fiber is used to guide laser pulses to a distal end of the catheter for occlusion removal. A high frequency train of small laser pulses is used as an energy source for a miniature ultrasonic transducer.
  • The portfolio also discloses techniques for directing pulses of radiation through optical fibers to generate a shock wave for breaking obstructions such as bubble or clots.
  • Techniques are also disclosed for detecting vapor bubble in liquid media by using lasers to generate acoustic signals.

Market Potential
This IP is an important portfolio for manufacturers of medical devices.

Companies who have cited this patent portfolio include:
Allergan, Endovasix Inc., Boston Scientific Scimed, Abbott Laboratories

To learn more about the assets available for sale in this portfolio:
Contact Dean Becker of ICAP Patent Brokerage at 561-309-0011 or Dean.Becker@us.icap.com

About LLNL

Founded in 1952, Lawrence Livermore National Laboratory provides solutions to our nation's most important national security challenges through innovative science, engineering and technology. Lawrence Livermore National Laboratory is managed by Lawrence Livermore National Security, LLC for the U.S. Department of Energy's National Nuclear Security Administration.

About ICAP Patent Brokerage

ICAP Patent Brokerage is a division of ICAP plc and the world's largest intellectual property brokerage and patent auction firm.

About ICAP

ICAP is the world's leading interdealer broker and provider of post trade risk and information services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, FX, emerging markets and equity derivatives through voice and electronic networks. Through our post trade risk and information services we help our customers manage and mitigate risks in their portfolios. For more information go to www.icap.com.


'/>"/>
SOURCE ICAP Patent Brokerage
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedPro Imaging to Repair GE E8/E9 Ultrasound Transducers
2. New Deep Vein Thrombosis (DVT) Registry Data Show Clot Quickly Removed, Blood Flow Restored in Large Patient Registry
3. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
4. Trellis(R) Catheter Removes Blood Clots Quickly, Restoring Blood Flow in 771 Deep Vein Thrombosis (DVT) Patients
5. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
6. FDA Begins Process To Remove Breast Cancer Indication From Avastin Label
7. NASDAQ Removes TLCR From Biotechnology Index Pending FTC Decision on Grifols Acquisition
8. FDA CONSUMER HEALTH INFORMATION - FDA Intends to Remove Unapproved Drugs From Market
9. FDA, FTC Act To Remove Fraudulent STD Products From The Market
10. Breast Cancer Patients and Families Decry FDA Panel Vote to Remove Life Saving Drug From Approved List
11. DMC Cardiovascular Institute Physician is First in Michigan to Use New "Arterial Drill" Catheterization Technique to Remove a Major Blockage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, ... today unveiled a new store design to enhance ... of healthier food, health-focused products and expanded beauty ... to help customers discover new offerings. Together with ... next evolution of the customer experience at CVS ...
(Date:4/20/2017)... Research and Markets has announced the ... Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies ... ... was valued at US$ 7,167.6 Mn in 2015, and is ... a CAGR of 5.6% from 2016 to 2024. ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies ... to help with process innovation in drug formulation and manufacturing. CoreRx offers ... state-of-the-art analytical equipment in support of their development and manufacturing goals. , ...
(Date:4/25/2017)... Plains, NJ (PRWEB) , ... April 25, 2017 , ... Saad B. Chaudhary, MD is ... the treatment of acute or chronic problems, I focus on preventative care with all my ... If you have any questions, always feel free to contact my office and my trained ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... ... April 24, 2017 , ... Michael Vick announced his retirement ... quarterback position. The former overall number one pick in the 2001 NFL Draft, to ... holds the record for the most career rushing yards by a quarterback (6,109) and ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
Breaking Medicine News(10 mins):